製品の概要

  • 製品名
    Methyllycaconitine citrate (MLA)
  • 製品の詳細
    α7 Nicotinic receptor antagonist
  • 別名
    • MLA
  • 生理活性の詳細
    Potent, selective antagonist at α7-containing nicotinic receptors.

    Also available in simple stock solutions (ab146684) - add 1 ml of water to get an exact, ready-to-use concentration.
  • 精製度
    > 98%

製品の特性

参考文献

This product has been referenced in:
  • Chilton M  et al. Behavioral consequences of methyllycaconitine in mice: a model of alpha7 nicotinic acetylcholine receptor deficiency. Life Sci 74:3133-9 (2004). Read more (PubMed: 15081578) »
  • Davies AR  et al. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-90 (1999). Read more (PubMed: 10340305) »
  • Whiteaker P  et al. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 11:2689-96 (1999). Read more (PubMed: 10457165) »

See all 4 Publications for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120072.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

登録